| scholarly article | Q13442814 |
| P50 | author | Damian E. Dupuy | Q37839798 |
| Hiran Fernando | Q44132114 | ||
| P2093 | author name string | Paul A Decker | |
| Varun Puri | |||
| Bryan Meyers | |||
| Traves Crabtree | |||
| Rebecca Paulus | |||
| Jeffrey Bradley | |||
| Robert Timmerman | |||
| Joe B Putnum | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| patient | Q181600 | ||
| P304 | page(s) | 692-699 | |
| P577 | publication date | 2012-11-20 | |
| P1433 | published in | The Journal of Thoracic and Cardiovascular Surgery | Q2795598 |
| P1476 | title | Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). | |
| P478 | volume | 145 |
| Q37193622 | A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032). |
| Q47877896 | A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors |
| Q42425652 | A prospective clinical trial of radiofrequency ablation for pulmonary metastases |
| Q36476137 | A retrospective comparative analysis of elderly and younger patients undergoing pulmonary resection for stage I non-small cell lung cancer |
| Q35200640 | Alternative to surgery in early stage NSCLC-interventional radiologic approaches |
| Q30585045 | Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy |
| Q35812234 | Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer |
| Q37468265 | Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer |
| Q35822727 | Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer |
| Q35996052 | Improving lung cancer outcomes by improving the quality of surgical care |
| Q38609742 | Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription |
| Q38903804 | Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation. |
| Q52613276 | Lung density change after SABR: A comparative study between tri-Co-60 magnetic resonance-guided system and linear accelerator. |
| Q38218238 | Managing lung cancer in high-risk patients: what to consider |
| Q93056809 | Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone |
| Q35687174 | Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers |
| Q38220335 | Novel treatment options in stage I non-small-cell lung cancer |
| Q38135436 | Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%). |
| Q44978333 | Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial |
| Q35663436 | Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer |
| Q47138257 | Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up |
| Q35057013 | Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? |
| Q33787072 | Radiofrequency ablation for early-stage nonsmall cell lung cancer |
| Q36462752 | Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors |
| Q36743276 | Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know |
| Q40813977 | Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial |
| Q58707448 | Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial |
| Q35764518 | Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes |
| Q55400828 | Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function. |
| Q35200592 | SBRT in operable early stage lung cancer patients. |
| Q47725017 | Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer |
| Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
| Q38560967 | Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients |
| Q38374340 | Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence? |
| Q36235528 | Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis |
| Q89617694 | Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm |
| Q52879860 | Surgical resection for clinical-Stage I radiological pure-solid lung cancer that met the current high risk criteria. |
| Q50138849 | The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer |
| Q33608344 | The impact of pulmonary hypertension on morbidity and mortality following major lung resection |
| Q51532645 | The present and future of thermal ablation for lung cancer. |
| Q35540262 | Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. |
| Q38110978 | Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? |
| Q47164549 | Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussion |
| Q34768714 | Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer |
| Q34499545 | Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates |
Search more.